ATE214942T1 - Fibrinogen-bildungsprotein - Google Patents

Fibrinogen-bildungsprotein

Info

Publication number
ATE214942T1
ATE214942T1 AT93921159T AT93921159T ATE214942T1 AT E214942 T1 ATE214942 T1 AT E214942T1 AT 93921159 T AT93921159 T AT 93921159T AT 93921159 T AT93921159 T AT 93921159T AT E214942 T1 ATE214942 T1 AT E214942T1
Authority
AT
Austria
Prior art keywords
formation protein
protein
fragment
fibrinogen formation
fibrinogen
Prior art date
Application number
AT93921159T
Other languages
English (en)
Inventor
Maria K Boden
Jan-Ingmar Flock
Original Assignee
Alfa Laval Agri Internat Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9202720A external-priority patent/SE9202720D0/xx
Priority claimed from SE9302955A external-priority patent/SE9302955D0/xx
Application filed by Alfa Laval Agri Internat Ab filed Critical Alfa Laval Agri Internat Ab
Application granted granted Critical
Publication of ATE214942T1 publication Critical patent/ATE214942T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93921159T 1992-09-21 1993-09-20 Fibrinogen-bildungsprotein ATE214942T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9202720A SE9202720D0 (sv) 1992-09-21 1992-09-21 Fibrinogen binding protein
SE9302955A SE9302955D0 (sv) 1993-09-13 1993-09-13 A fibrinogen binding protein
PCT/SE1993/000759 WO1994006830A1 (en) 1992-09-21 1993-09-20 Fibrinogen binding protein

Publications (1)

Publication Number Publication Date
ATE214942T1 true ATE214942T1 (de) 2002-04-15

Family

ID=26661530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921159T ATE214942T1 (de) 1992-09-21 1993-09-20 Fibrinogen-bildungsprotein

Country Status (7)

Country Link
US (1) US6299879B1 (de)
EP (1) EP0621875B1 (de)
AT (1) ATE214942T1 (de)
AU (1) AU4837193A (de)
CA (1) CA2124210A1 (de)
DE (1) DE69331758T2 (de)
WO (1) WO1994006830A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
WO1995034655A2 (en) * 1994-06-07 1995-12-21 The Rockefeller University Surface protein of staphylococcus aureus
SE9402490D0 (sv) * 1994-07-15 1994-07-15 Jan Ingmar Flock Vitronection binding protein
EP0859845A1 (de) * 1995-10-16 1998-08-26 Smithkline Beecham Plc Neuartige verbindungen von zelloberflaechenproteinen
US6013482A (en) 1996-10-15 2000-01-11 Smithkline Beecham Plc Cell surface protein compounds
US5700928A (en) * 1995-10-16 1997-12-23 Smithkline Beecham, P.L.C. Polynucleotide encoding saliva binding protein
US5858709A (en) * 1996-10-15 1999-01-12 Smithkline Beecham P.L.C. Fibronectin binding protein B compounds
GB9521146D0 (en) * 1995-10-16 1995-12-20 Smithkline Beecham Plc Novel compounds
SE9602496D0 (sv) * 1996-06-20 1996-06-20 Bengt Guss Method and means for producing a fibrinogen binding protein and its use in biotechnology
US6107071A (en) * 1996-09-24 2000-08-22 Smithkline Beecham Corporation Histidinol dehydrogenase
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
EP2319931A1 (de) * 1997-11-26 2011-05-11 Inhibitex, Inc. Extrazellulären Matrix-bindende Proteine von Staphilococcus aureus
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
WO2003041726A1 (en) * 2001-11-16 2003-05-22 Biostapro Ab Use of an extracellular adherence protein for the manufacture of an anti-inflammatory drug
US20030105020A1 (en) * 2001-11-16 2003-06-05 Jan-Ingmar Flock Use of a composition
US20070053925A1 (en) * 2003-04-16 2007-03-08 Eric Brown Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
WO2005005630A2 (en) 2003-07-08 2005-01-20 Umc Utrecht Holding B.V. Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases
EP2503008B1 (de) 2007-04-19 2015-04-01 Molecular Detection Inc. Verfahren, Zusammensetzungen und Kits zur Erkennung und Analyse von Antibiotika-resistenten Bakterien
CA2697538C (en) * 2007-08-31 2019-02-12 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
US8758765B2 (en) * 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
WO2011005341A2 (en) 2009-04-03 2011-01-13 University Of Chicago Compositions and methods related to protein a (spa) variants
AU2011274367B2 (en) 2010-07-02 2015-04-23 The University Of Chicago Compositions and methods related to protein A (SpA) variants
CN101987866B (zh) * 2010-10-25 2013-01-23 中国人民解放军军事医学科学院基础医学研究所 金黄色葡萄球菌Efb蛋白C端抗原表位及其制备方法和用途
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
WO2015112895A2 (en) * 2014-01-24 2015-07-30 Church William R Antibody specific to staphylococcus aureus, therapeutic method and detection method using same
US11345744B2 (en) 2019-05-07 2022-05-31 William R Church Antibody specific to Staphylococcus aureus, therapeutic method and detection method using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454403B (sv) * 1984-05-30 1988-05-02 Alfa Laval Agri Int Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
US5189015A (en) 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability

Also Published As

Publication number Publication date
WO1994006830A1 (en) 1994-03-31
CA2124210A1 (en) 1994-03-31
AU4837193A (en) 1994-04-12
EP0621875A1 (de) 1994-11-02
DE69331758T2 (de) 2002-11-14
EP0621875B1 (de) 2002-03-27
DE69331758D1 (de) 2002-05-02
US6299879B1 (en) 2001-10-09

Similar Documents

Publication Publication Date Title
ATE214942T1 (de) Fibrinogen-bildungsprotein
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO901399D0 (no) Aminosyrederivater.
DK1175909T3 (da) Terapeutiske sammensætninger af antistoffer og antisense-nukleinsyrer mod Serrate
NO901033L (no) Aminosyrederivater.
NO903832D0 (no) Aminosyrederivater.
ATE165976T1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
AP9200410A0 (en) Retroviral protease inhibitors.
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
DK162421C (da) Hundeparvovirus-vaccine, fremgangsmaade til fremstilling heraf og virusstamme til brug i vaccinen
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
ATE220688T1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
NO884434D0 (no) Aminosyrederivater.
NO901533D0 (no) Aminosyrederivater.
DK675389A (da) Terapeutiske praeparater til forebyggelse af fibrinaflejringer
DE3875859D1 (de) Zubereitungen zur verbesserung der adcc-therapien.
ES2092067T3 (es) Procedimiento de purificacion de una proteina altamente glicosilada.
DE69433745D1 (de) Modifizierte, verkürzte regulatoren des komplementsystems
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
NO901519L (no) Aminosyrederivater.
ES504996A0 (es) Un procedimiento para aislar un polipeptido purificado
NO880034D0 (no) Fremgangsmaate for fremstilling av krystallinsk aminobeskyttet beta-benzyl-l-aspartinsyre.
BRPI9715268B8 (pt) preparações farmacêuticas liofilizadas estáveis de anticorpos monoclonais ou policlonais, bem como processo para sua produção
ATE82018T1 (de) Antigen aktive aminosaeuresequenzen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties